Tumor Metabolism of Head and Neck Cancer in Patients Who Underwent Radiation Therapy Measured With F-18-FDG-PET

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00180245

Enrollment

Registered

2005-09-16

Start date

2005-07-31

Completion date

2015-12-31

Last updated

2016-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Cancer

Keywords

Radiation therapy, F-18-FDG

Brief summary

The purpose of the study is to describe the regional and global FDG-kinetics in head and neck cancer during percutaneous radiation therapy.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

* Histologically confirmed head and neck cancer not curable by surgery * Karnofsky \> 70% * Tumor volume and localization allow curative radiotherapy * Written consent

Exclusion criteria

* Metastases * Earlier radiotherapy of head or neck * Pregnancy * Secondary malignancy excluding dermal carcinoma T1 and Tis-carcinoma of cervix uteri * Psychiatric impairment

Countries

Germany

Outcome results